Table 2.
Randomization Sequence |
Concealment | Blinding of Participant and Clinician |
Blinding of Outcome Assessment |
Incomplete Outcome Data | Selective Reporting |
Others | ||
---|---|---|---|---|---|---|---|---|
our analysis | de Jonge 2022 [12] | low | low | high | low | low | low | low |
Kumar 2020 [22] | low | low | high | low | low | low | low | |
Ram 2021 [25] | low | low | high | unclear | low | unclear | unclear | |
Stern analysis | Aguilar-Guisado 2017 [19] | low | low | high | high | low | low | low |
Bjornsson 1977 [20] | unclear | unclear | high | high | low | high | low | |
Klaassen 2000 [21] | low | low | low | low | low | low | low | |
Pizzo 1979 [24] | unclear | unclear | high | high | low | high | unclear | |
Pizzo 1982 [23] | unclear | unclear | high | high | low | high | unclear | |
Rodriguez 1973 [26] | unclear | unclear | high | high | low | high | unclear | |
Santolaya 1997 [28] | unclear | unclear | high | high | low | high | unclear | |
Santolaya 2017 [27] | unclear | unclear | high | low | low | high | low | |
low (%) | 45.5 | 45.5 | 9.1 | 36.4 | 100.0 | 36.4 | 54.5 | |
unclear (%) | 54.5 | 54.5 | 0.0 | 9.1 | 0.0 | 9.1 | 45.5 | |
high (%) | 0.0 | 0.0 | 90.9 | 54.5 | 0.0 | 54.5 | 0.0 |